BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16115014)

  • 1. Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement.
    Trimmer PA; Borland MK
    Antioxid Redox Signal; 2005; 7(9-10):1101-9. PubMed ID: 16115014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Fang D; Swerdlow RH; Yu H; Chen JX; Yan SS
    J Alzheimers Dis; 2016 Sep; 54(2):679-90. PubMed ID: 27567872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.
    Trimmer PA; Swerdlow RH; Parks JK; Keeney P; Bennett JP; Miller SW; Davis RE; Parker WD
    Exp Neurol; 2000 Mar; 162(1):37-50. PubMed ID: 10716887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
    J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's disease.
    Sheehan JP; Swerdlow RH; Miller SW; Davis RE; Parks JK; Parker WD; Tuttle JB
    J Neurosci; 1997 Jun; 17(12):4612-22. PubMed ID: 9169522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Du F; Yu Q; Yan SS
    J Alzheimers Dis; 2021; 81(4):1749-1761. PubMed ID: 33998543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy.
    Trimmer PA; Schwartz KM; Borland MK; De Taboada L; Streeter J; Oron U
    Mol Neurodegener; 2009 Jun; 4():26. PubMed ID: 19534794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines.
    Silva DF; Selfridge JE; Lu J; E L; Roy N; Hutfles L; Burns JM; Michaelis EK; Yan S; Cardoso SM; Swerdlow RH
    Hum Mol Genet; 2013 Oct; 22(19):3931-46. PubMed ID: 23740939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer.
    Esteves AR; Lu J; Rodova M; Onyango I; Lezi E; Dubinsky R; Lyons KE; Pahwa R; Burns JM; Cardoso SM; Swerdlow RH
    J Neurochem; 2010 May; 113(3):674-82. PubMed ID: 20132468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids.
    Flax J; Wilkins HM; Miller R; Griffith S; Cork GK; Qiang A; Thompson J; Swerdlow RH; Slawson C
    J Alzheimers Dis; 2020; 78(4):1743-1753. PubMed ID: 33285636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background.
    Esteves AR; Domingues AF; Ferreira IL; Januário C; Swerdlow RH; Oliveira CR; Cardoso SM
    Mitochondrion; 2008 Jun; 8(3):219-28. PubMed ID: 18495557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclical mitochondrial deltapsiM fluctuations linked to electron transport, F0F1 ATP-synthase and mitochondrial Na+/Ca+2 exchange are reduced in Alzheimer's disease cybrids.
    Thiffault C; Bennett JP
    Mitochondrion; 2005 Apr; 5(2):109-19. PubMed ID: 16050977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
    Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
    J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A NH2 tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration.
    Amadoro G; Corsetti V; Stringaro A; Colone M; D'Aguanno S; Meli G; Ciotti M; Sancesario G; Cattaneo A; Bussani R; Mercanti D; Calissano P
    J Alzheimers Dis; 2010; 21(2):445-70. PubMed ID: 20571215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells.
    De Sarno P; Bijur GN; Lu R; Davis RE; Jope RS
    Neurobiol Aging; 2000; 21(1):31-8. PubMed ID: 10794846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease.
    Ghosh SS; Swerdlow RH; Miller SW; Sheeman B; Parker WD; Davis RE
    Ann N Y Acad Sci; 1999; 893():176-91. PubMed ID: 10672237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture.
    Trimmer PA; Keeney PM; Borland MK; Simon FA; Almeida J; Swerdlow RH; Parks JP; Parker WD; Bennett JP
    Neurobiol Dis; 2004 Feb; 15(1):29-39. PubMed ID: 14751768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired lysosomal cobalamin transport in Alzheimer's disease.
    Zhao H; Li H; Ruberu K; Garner B
    J Alzheimers Dis; 2015; 43(3):1017-30. PubMed ID: 25125476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients.
    Swerdlow RH; Parks JK; Cassarino DS; Shilling AT; Bennett JP; Harrison MB; Parker WD
    Biochem Biophys Res Commun; 1999 Aug; 261(3):701-4. PubMed ID: 10441489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.